avatar
KNOCK-IN animal design# Biology - 生物学
w*a
1
想请教一下有经验的前辈,如果跳槽的话,在原来学校的专利怎么办?
1)如果还在Provisional patent阶段,但是有希望转成正式的patent。那么跳槽以后
还可以跟原来学校一起申请正式的patent吗?
2)如果是已经申请或者批准了正式的patent呢?如果跳了槽,到时候如果可以转化的
话,会影响到跟原来学校分钱吗??
多谢!!
avatar
o*l
2
想先去摸摸
avatar
k*n
3
如果顾虑HETEROZYGOUS KNOCK-IN会导致整个动物因为神经功能问题不能繁殖,
HOMOZYGOUS肯定会死,整体设计思路应该是怎样?CONDITIONAL KNOCK-IN?
avatar
s*t
4
跳槽以后应该是可以跟以前的学校一起申请non provisional 的。分钱的话我的理解是
申请的时候就说好了比例是多少,跟你在不在那个学校应该没有关系。
恭喜啊, 这年头能有分到钱的专利不容易!

【在 w********a 的大作中提到】
: 想请教一下有经验的前辈,如果跳槽的话,在原来学校的专利怎么办?
: 1)如果还在Provisional patent阶段,但是有希望转成正式的patent。那么跳槽以后
: 还可以跟原来学校一起申请正式的patent吗?
: 2)如果是已经申请或者批准了正式的patent呢?如果跳了槽,到时候如果可以转化的
: 话,会影响到跟原来学校分钱吗??
: 多谢!!

avatar
Z*g
5
据说周五。
avatar
z*u
6
conditional knockout.
avatar
d*h
7
公司的思路不一样
隔壁学校很牛逼的华人教授我觉得纯灌水的结果卖了好几百万
要么药厂sb要么我sb

【在 s**********t 的大作中提到】
: 跳槽以后应该是可以跟以前的学校一起申请non provisional 的。分钱的话我的理解是
: 申请的时候就说好了比例是多少,跟你在不在那个学校应该没有关系。
: 恭喜啊, 这年头能有分到钱的专利不容易!

avatar
S*9
8
你这个想overexpression还是knockdown啊?
做flox老鼠吧
avatar
w*a
9
想请教一下有经验的前辈,如果跳槽的话,在原来学校的专利怎么办?
1)如果还在Provisional patent阶段,但是有希望转成正式的patent。那么跳槽以后
还可以跟原来学校一起申请正式的patent吗?
2)如果是已经申请或者批准了正式的patent呢?如果跳了槽,到时候如果可以转化的
话,会影响到跟原来学校分钱吗??
多谢!!
avatar
k*n
10
需要做KNOCK-IN OVEREXPRESSION, KNOCKOUT 没有表型。
avatar
s*t
11
跳槽以后应该是可以跟以前的学校一起申请non provisional 的。分钱的话我的理解是
申请的时候就说好了比例是多少,跟你在不在那个学校应该没有关系。
恭喜啊, 这年头能有分到钱的专利不容易!

【在 w********a 的大作中提到】
: 想请教一下有经验的前辈,如果跳槽的话,在原来学校的专利怎么办?
: 1)如果还在Provisional patent阶段,但是有希望转成正式的patent。那么跳槽以后
: 还可以跟原来学校一起申请正式的patent吗?
: 2)如果是已经申请或者批准了正式的patent呢?如果跳了槽,到时候如果可以转化的
: 话,会影响到跟原来学校分钱吗??
: 多谢!!

avatar
H*N
12
make it inducible
avatar
d*h
13
公司的思路不一样
隔壁学校很牛逼的华人教授我觉得纯灌水的结果卖了好几百万
要么药厂sb要么我sb

【在 s**********t 的大作中提到】
: 跳槽以后应该是可以跟以前的学校一起申请non provisional 的。分钱的话我的理解是
: 申请的时候就说好了比例是多少,跟你在不在那个学校应该没有关系。
: 恭喜啊, 这年头能有分到钱的专利不容易!

avatar
w*e
14
overexpression does not have to use knockin at ROSA26 locus. Transgenic
approach can achieve higher dosage.

【在 k********n 的大作中提到】
: 需要做KNOCK-IN OVEREXPRESSION, KNOCKOUT 没有表型。
avatar
w*a
15
多谢回复!

【在 s**********t 的大作中提到】
: 跳槽以后应该是可以跟以前的学校一起申请non provisional 的。分钱的话我的理解是
: 申请的时候就说好了比例是多少,跟你在不在那个学校应该没有关系。
: 恭喜啊, 这年头能有分到钱的专利不容易!

avatar
l*y
16
Assume your knock-in here refers to mutating a site at the endogenous locus
(thus over expression-type approach, such as making transgenic mouse from
Rosa26 locus, will not be applied here).
Then the question is: you expect your mutation is a gain-of-function
mutation or loss-of-function mutation.
If your mutation is GOF mutation, it is easy, see Kras V12 KI strategy--
basically insert stopper element LSL before Kras V12 Exon. Note that the
allele LSL Kras V12 (before crossing with Cre) is a null allele, because
stopper will disrupt Kras expression, so you have to use heterozygous mice
in your study---After you cross with cre, You have 50% WT Kras, 50% Kras V12
. however
, this is fine because you are studying a GOF mutation.
If you are studying a LOF mutation (say, study a kinase dead mutant), then
the same conditional KI strategy mentioned above cannot be applied here.
first, you cannot use homozygous Conditional KI mice, because phenotypically
they are total KO. If you use heterozygous mice, then eventually the mice
have half WT kinase, half kinase dead mutant---you might not see any
phenotype(unless you expect strong dominant negative effect).
As far as I know, currently there is no good way to use conditional KI to
study LOF mutant.

【在 k********n 的大作中提到】
: 如果顾虑HETEROZYGOUS KNOCK-IN会导致整个动物因为神经功能问题不能繁殖,
: HOMOZYGOUS肯定会死,整体设计思路应该是怎样?CONDITIONAL KNOCK-IN?

avatar
w*a
17
多谢回复!

【在 s**********t 的大作中提到】
: 跳槽以后应该是可以跟以前的学校一起申请non provisional 的。分钱的话我的理解是
: 申请的时候就说好了比例是多少,跟你在不在那个学校应该没有关系。
: 恭喜啊, 这年头能有分到钱的专利不容易!

avatar
k*n
18
Thanks a lot, Lumphy.
The mutant has dominant-negative effects and we would like to make a
inducible KI (so it is GOF) since I am sure homo will die and hetero will no
be able to breed. We would like to have rat line instead mice due to its
larger size for microsurgery on infant animals and better characterized
behavior.
Mutating at the endogenous locus or over-expression at Rosa26 locus will, I
believe, give the same phenotype. Which one is easier, simpler and faster?
Regarding the Kras v12 strategy, would you give me a reference?

locus
V12

【在 l****y 的大作中提到】
: Assume your knock-in here refers to mutating a site at the endogenous locus
: (thus over expression-type approach, such as making transgenic mouse from
: Rosa26 locus, will not be applied here).
: Then the question is: you expect your mutation is a gain-of-function
: mutation or loss-of-function mutation.
: If your mutation is GOF mutation, it is easy, see Kras V12 KI strategy--
: basically insert stopper element LSL before Kras V12 Exon. Note that the
: allele LSL Kras V12 (before crossing with Cre) is a null allele, because
: stopper will disrupt Kras expression, so you have to use heterozygous mice
: in your study---After you cross with cre, You have 50% WT Kras, 50% Kras V12

avatar
l*y
19
You can check Tyler Jacks, 2003 Cancer Cell paper.
Transgenic approach in general is easier, cheaper and faster, but may be
criticized for its intrinsic overexpression limitation. For example, Kras
mutant over expression and expression at endogenous level (by KI) lead to
different cellular phenotypes, but KI mimics more what happens in cancer
patients.

no
I

【在 k********n 的大作中提到】
: Thanks a lot, Lumphy.
: The mutant has dominant-negative effects and we would like to make a
: inducible KI (so it is GOF) since I am sure homo will die and hetero will no
: be able to breed. We would like to have rat line instead mice due to its
: larger size for microsurgery on infant animals and better characterized
: behavior.
: Mutating at the endogenous locus or over-expression at Rosa26 locus will, I
: believe, give the same phenotype. Which one is easier, simpler and faster?
: Regarding the Kras v12 strategy, would you give me a reference?
:

avatar
x*e
20
loxp STOP loxp gene应该是最保险的吧

【在 k********n 的大作中提到】
: 如果顾虑HETEROZYGOUS KNOCK-IN会导致整个动物因为神经功能问题不能繁殖,
: HOMOZYGOUS肯定会死,整体设计思路应该是怎样?CONDITIONAL KNOCK-IN?

avatar
x*e
21
LOF的情况下WT allele被floxed就可以了吧?

locus
V12

【在 l****y 的大作中提到】
: Assume your knock-in here refers to mutating a site at the endogenous locus
: (thus over expression-type approach, such as making transgenic mouse from
: Rosa26 locus, will not be applied here).
: Then the question is: you expect your mutation is a gain-of-function
: mutation or loss-of-function mutation.
: If your mutation is GOF mutation, it is easy, see Kras V12 KI strategy--
: basically insert stopper element LSL before Kras V12 Exon. Note that the
: allele LSL Kras V12 (before crossing with Cre) is a null allele, because
: stopper will disrupt Kras expression, so you have to use heterozygous mice
: in your study---After you cross with cre, You have 50% WT Kras, 50% Kras V12

avatar
l*y
22
Not sure about your point here.
For example, if you are studying a kinase function in neurobiology. You
found total KO of your gene leads to embryonic lethal phenotype, and
conditional KO of your gene in neuron leads to very interesting phenotype.
Culturing of KO neuron in vitro also showed dramatic phenotype.
Interestingly, restoration of kinase dead (KD) mutant in KO neuron fully
rescued the phenotype (same as restoration of WT).
You wonder whether the neuronal phenotype you observed in vivo is kinase
function dependent or not, so you first generated a germline kinase dead
knock-in (KI) mice (in which you only mutated one residue in kinase domain
which is critical to maintain kinase function). However, KI/KI homozygous
mice is lethal (because kinase function is important for embryo development)
, while KI/+ heterozygous mouse are normal (because 50% WT kinase in the
cell can still do its job).
Now you want to generate a conditional KI mouse in which you can switch WT
protein to KD protein in adult neuron and see what happens. This is the same
idea for conditional KO approach: as long as you have an appropriate Cre,
you can switch off the expression of your gene at specific time and place.
However, as far as I know, there is no straight forward conditional KI
approach to afford this purpose.
The loxp-stop-loxp (LSL) approach cannot be applied here. Because LSL-KD
allele is a null allele. If you generate LSL-KD/+ mice, after you cross with
cre, you generate KD/+ genotype in neuron. You will not expect to see any
phenotype, because 50% WT kinase can still do its job (this is different
from LSL Kras KI/+ case, because Kras mutation is a gain-of-function
mutation, the mutation can have effect even there are 50% additional WT Kras
). If you generate LSL-KD/LSK-KD homozygous mice, it is lethal. You cannot
obtain such viable mice.
You can use transgenic approach to induce the expression of your kinase dead
mutant in neuron. However, this is not knock-in we are talking about here
and carries its own limitation as I mentioned above.

【在 x********e 的大作中提到】
: LOF的情况下WT allele被floxed就可以了吧?
:
: locus
: V12

avatar
x*e
23
Cre, LSL-KD/+没表型应该是fertile的吧?把这个line跟floxed WT line cross,得到
Cre, LSL-KD/floxed WT。如果用合适的Cre,能否得到KD/-?

【在 l****y 的大作中提到】
: Not sure about your point here.
: For example, if you are studying a kinase function in neurobiology. You
: found total KO of your gene leads to embryonic lethal phenotype, and
: conditional KO of your gene in neuron leads to very interesting phenotype.
: Culturing of KO neuron in vitro also showed dramatic phenotype.
: Interestingly, restoration of kinase dead (KD) mutant in KO neuron fully
: rescued the phenotype (same as restoration of WT).
: You wonder whether the neuronal phenotype you observed in vivo is kinase
: function dependent or not, so you first generated a germline kinase dead
: knock-in (KI) mice (in which you only mutated one residue in kinase domain

avatar
l*y
24
Yes, this is the best we can do currently using LSL to study KI. I previousl
so basically, before crossing with cre, the target cells have 50% WT protein
, after crossing with cre, the target cells have 50% kinase dead protein.
Do you know whether there is any such publication using this mating strategy?

【在 x********e 的大作中提到】
: Cre, LSL-KD/+没表型应该是fertile的吧?把这个line跟floxed WT line cross,得到
: Cre, LSL-KD/floxed WT。如果用合适的Cre,能否得到KD/-?

avatar
x*e
25
我不是做老鼠的,不太清楚

previousl
protein
strategy?

【在 l****y 的大作中提到】
: Yes, this is the best we can do currently using LSL to study KI. I previousl
: so basically, before crossing with cre, the target cells have 50% WT protein
: , after crossing with cre, the target cells have 50% kinase dead protein.
: Do you know whether there is any such publication using this mating strategy?

相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。